10-Q Filing

INTUITIVE SURGICAL INC CIK: 1035267 Q2 2018

Filing Information

Form Type	10-Q
Accession Number	`0001035267-18-000084`
Period End Date	20180630
Filing Date	20180720
Fiscal Year	2018
Fiscal Period	Q2
XBRL Instance	isrg-20180630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 78 Income Statement 88 Cash Flow Statement 66

Balance Sheet 78 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	2.50M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	2.50M	shares	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.20B	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$648.20M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Short-term investments	`MarketableSecuritiesCurrent`	$1.73B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Short-term investments	`MarketableSecuritiesCurrent`	$1.31B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$507.90M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$532.50M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Inventory	`InventoryNet`	$331.50M	USD	Point-in-time
Inventory	`InventoryNet`	$241.20M	USD	Point-in-time
Prepaids and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$189.60M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	112.30M	shares	Point-in-time
Prepaids and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$99.20M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	113.70M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$3.99B	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	112.30M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$2.81B	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	113.70M	shares	Point-in-time
Property, plant, and equipment, net	`PropertyPlantAndEquipmentNet`	$688.80M	USD	Point-in-time
Property, plant, and equipment, net	`PropertyPlantAndEquipmentNet`	$613.10M	USD	Point-in-time
Long-term investments	`MarketableSecuritiesNoncurrent`	$1.33B	USD	Point-in-time
Long-term investments	`MarketableSecuritiesNoncurrent`	$1.89B	USD	Point-in-time
Deferred tax assets	`DeferredTaxAssetsNetNoncurrent`	$415.40M	USD	Point-in-time
Deferred tax assets	`DeferredTaxAssetsNetNoncurrent`	$72.00M	USD	Point-in-time
Intangible and other assets, net	`IntangibleAndOtherAssets`	$195.80M	USD	Point-in-time
Intangible and other assets, net	`IntangibleAndOtherAssets`	$221.30M	USD	Point-in-time
Goodwill	`Goodwill`	$210.90M	USD	Point-in-time
Goodwill	`Goodwill`	$201.10M	USD	Point-in-time
Total assets	`Assets`	$5.78B	USD	Point-in-time
Total assets	`Assets`	$6.85B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$102.20M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$82.50M	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$128.00M	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$167.60M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$272.10M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$243.80M	USD	Point-in-time
Other accrued liabilities	`OtherLiabilitiesCurrent`	$168.90M	USD	Point-in-time
Other accrued liabilities	`OtherLiabilitiesCurrent`	$164.10M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$666.40M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$662.80M	USD	Point-in-time
Other long-term liabilities	`LiabilitiesOtherThanLongtermDebtNoncurrent`	$314.00M	USD	Point-in-time
Other long-term liabilities	`LiabilitiesOtherThanLongtermDebtNoncurrent`	$333.60M	USD	Point-in-time
Total liabilities	`Liabilities`	$980.40M	USD	Point-in-time
Total liabilities	`Liabilities`	$996.40M	USD	Point-in-time
Contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; no shares issued and outstanding as of June 30, 2018, and December 31, 2017	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; no shares issued and outstanding as of June 30, 2018, and December 31, 2017	`PreferredStockValue`	-	USD	Point-in-time
Common stock, 300.0 shares authorized, $0.001 par value, 113.7 shares and 112.3 shares issued and outstanding as of June 30, 2018, and December 31, 2017, respectively	`CommonStockValue`	$100.00K	USD	Point-in-time
Common stock, 300.0 shares authorized, $0.001 par value, 113.7 shares and 112.3 shares issued and outstanding as of June 30, 2018, and December 31, 2017, respectively	`CommonStockValue`	$100.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$4.68B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$4.93B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$948.10M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$115.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-8.90M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-8.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-9.80M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-15.50M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-16.40M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-18.10M	USD	Point-in-time
Total Intuitive Surgical, Inc. stockholders equity	`StockholdersEquity`	$4.78B	USD	Point-in-time
Total Intuitive Surgical, Inc. stockholders equity	`StockholdersEquity`	$5.86B	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$8.60M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$1.60M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.87B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.78B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$5.78B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$6.85B	USD	Point-in-time

Income Statement 88 line items

Line Item	Tag	Value	Unit	Period
Product	`SalesRevenueGoodsNet`	$618.90M	USD	1 Quarter
Product	`SalesRevenueGoodsNet`	$1.16B	USD	2 Qtrs
Product	`SalesRevenueGoodsNet`	$753.50M	USD	1 Quarter
Product	`SalesRevenueGoodsNet`	$1.45B	USD	2 Qtrs
Service	`SalesRevenueServicesNet`	$139.90M	USD	1 Quarter
Service	`SalesRevenueServicesNet`	$277.90M	USD	2 Qtrs
Service	`SalesRevenueServicesNet`	$308.50M	USD	2 Qtrs
Service	`SalesRevenueServicesNet`	$155.80M	USD	1 Quarter
Total revenue	`SalesRevenueNet`	$1.76B	USD	2 Qtrs
Total revenue	`SalesRevenueNet`	$909.30M	USD	1 Quarter
Total revenue	`SalesRevenueNet`	$758.80M	USD	1 Quarter
Total revenue	`SalesRevenueNet`	$1.44B	USD	2 Qtrs
Product	`CostOfGoodsSold`	$350.20M	USD	2 Qtrs
Product	`CostOfGoodsSold`	$429.60M	USD	2 Qtrs
Product	`CostOfGoodsSold`	$184.70M	USD	1 Quarter
Product	`CostOfGoodsSold`	$228.10M	USD	1 Quarter
Service	`CostOfServices`	$101.10M	USD	2 Qtrs
Service	`CostOfServices`	$48.90M	USD	1 Quarter
Service	`CostOfServices`	$88.30M	USD	2 Qtrs
Service	`CostOfServices`	$44.00M	USD	1 Quarter
Total cost of revenue	`CostOfRevenue`	$438.50M	USD	2 Qtrs
Total cost of revenue	`CostOfRevenue`	$530.70M	USD	2 Qtrs
Total cost of revenue	`CostOfRevenue`	$277.00M	USD	1 Quarter
Total cost of revenue	`CostOfRevenue`	$228.70M	USD	1 Quarter
Gross profit	`GrossProfit`	$632.30M	USD	1 Quarter
Gross profit	`GrossProfit`	$999.90M	USD	2 Qtrs
Gross profit	`GrossProfit`	$1.23B	USD	2 Qtrs
Gross profit	`GrossProfit`	$530.10M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$259.80M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$185.60M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$388.50M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$481.40M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$158.10M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$95.10M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$190.60M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$84.60M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$354.90M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$672.00M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$270.20M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$546.60M	USD	2 Qtrs
Income from operations	`OperatingIncomeLoss`	$554.10M	USD	2 Qtrs
Income from operations	`OperatingIncomeLoss`	$277.40M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$453.30M	USD	2 Qtrs
Income from operations	`OperatingIncomeLoss`	$259.90M	USD	1 Quarter
Interest and other income, net	`NonoperatingIncomeExpense`	$18.80M	USD	2 Qtrs
Interest and other income, net	`NonoperatingIncomeExpense`	$10.10M	USD	1 Quarter
Interest and other income, net	`NonoperatingIncomeExpense`	$31.40M	USD	2 Qtrs
Interest and other income, net	`NonoperatingIncomeExpense`	$18.20M	USD	1 Quarter
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$585.50M	USD	2 Qtrs
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$295.60M	USD	1 Quarter
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$472.10M	USD	2 Qtrs
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$270.00M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$41.00M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$68.30M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$47.00M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$43.60M	USD	2 Qtrs
Net income	`ProfitLoss`	$403.80M	USD	2 Qtrs
Net income	`ProfitLoss`	$254.60M	USD	1 Quarter
Net income	`ProfitLoss`	$223.00M	USD	1 Quarter
Net income	`ProfitLoss`	$541.90M	USD	2 Qtrs
Less: net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.00M	USD	2 Qtrs
Less: net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Less: net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	2 Qtrs
Less: net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-700.00K	USD	1 Quarter
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$542.90M	USD	2 Qtrs
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$255.30M	USD	1 Quarter
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$223.00M	USD	1 Quarter
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$403.80M	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$3.62	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$2.01	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$2.25	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$4.80	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.50	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.94	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$4.59	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$2.15	USD	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	113.50M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	111.00M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	111.60M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	113.20M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	115.20M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	115.50M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	118.50M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	118.30M	shares	2 Qtrs
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$402.90M	USD	2 Qtrs
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$221.20M	USD	1 Quarter
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$257.00M	USD	1 Quarter
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$542.00M	USD	2 Qtrs

Cash Flow Statement 66 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$403.80M	USD	2 Qtrs
Net income	`ProfitLoss`	$254.60M	USD	1 Quarter
Net income	`ProfitLoss`	$223.00M	USD	1 Quarter
Net income	`ProfitLoss`	$541.90M	USD	2 Qtrs
Depreciation and loss on disposal of property, plant, and equipment	`Depreciation`	$49.80M	USD	2 Qtrs
Depreciation and loss on disposal of property, plant, and equipment	`Depreciation`	$39.60M	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$7.00M	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$5.70M	USD	2 Qtrs
Loss on investments, accretion of discounts, and amortization of premiums on investments, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-11.40M	USD	2 Qtrs
Loss on investments, accretion of discounts, and amortization of premiums on investments, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-4.70M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$35.50M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$48.70M	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$97.80M	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$120.80M	USD	2 Qtrs
Amortization of contract acquisition asset	`CapitalizedContractCostAmortization`	$5.30M	USD	2 Qtrs
Amortization of contract acquisition asset	`CapitalizedContractCostAmortization`	$5.50M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$17.30M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$51.40M	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$58.30M	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$133.90M	USD	2 Qtrs
Prepaids and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$47.90M	USD	2 Qtrs
Prepaids and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$102.40M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$5.70M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$14.30M	USD	2 Qtrs
Accrued compensation and employee benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-39.60M	USD	2 Qtrs
Accrued compensation and employee benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-24.90M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$40.30M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$29.80M	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-16.10M	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-6.10M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$458.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$511.70M	USD	2 Qtrs
Purchase of investments	`PaymentsToAcquireMarketableSecurities`	$851.60M	USD	2 Qtrs
Purchase of investments	`PaymentsToAcquireMarketableSecurities`	$707.00M	USD	2 Qtrs
Proceeds from sales of investments	`ProceedsFromSaleOfAvailableForSaleSecurities`	$1.47B	USD	2 Qtrs
Proceeds from sales of investments	`ProceedsFromSaleOfAvailableForSaleSecurities`	$259.00M	USD	2 Qtrs
Proceeds from maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$724.90M	USD	2 Qtrs
Proceeds from maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$294.90M	USD	2 Qtrs
Purchase of property, plant, and equipment and intellectual property	`PaymentsToAcquireProductiveAssets`	$84.90M	USD	2 Qtrs
Purchase of property, plant, and equipment and intellectual property	`PaymentsToAcquireProductiveAssets`	$108.30M	USD	2 Qtrs
Payments to Acquire Businesses, Net of Cash Acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	2 Qtrs
Payments to Acquire Businesses, Net of Cash Acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$38.10M	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$954.50M	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$9.30M	USD	2 Qtrs
Proceeds from issuance of common stock relating to employee stock plans	`ProceedsFromStockPlans`	$296.40M	USD	2 Qtrs
Proceeds from issuance of common stock relating to employee stock plans	`ProceedsFromStockPlans`	$134.90M	USD	2 Qtrs
Taxes paid related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$50.00M	USD	2 Qtrs
Taxes paid related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$108.00M	USD	2 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$2.00B	USD	2 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	2 Qtrs
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	-	USD	2 Qtrs
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$8.00M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.75B	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$34.90M	USD	2 Qtrs
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-600.00K	USD	2 Qtrs
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$1.00M	USD	2 Qtrs
Net increase (decrease) in cash, cash equivalents, and restricted cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$555.30M	USD	2 Qtrs
Net increase (decrease) in cash, cash equivalents, and restricted cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-340.10M	USD	2 Qtrs
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$663.20M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.05B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.22B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$711.50M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.05B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.22B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$663.20M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$711.50M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.